{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-004521","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2023-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.313718+00:00","generated_at":"2026-06-19T15:57:07.373936+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GlucoTrack receives Nasdaq extension to May 22, 2023 for compliance with listing rule 5550(b)","bullets":["Nasdaq granted extension until May 22, 2023 to meet minimum $2.5M stockholders' equity, $35M market value, or $500K net income.","Company was initially notified of noncompliance on November 22, 2022.","Compliance may be achieved through acquisition or equity capital raise on or before May 22, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-004521","json":"https://secwatch.observer/filing/0001493152-23-004521.json","markdown":"https://secwatch.observer/filing/0001493152-23-004521.md","text":"https://secwatch.observer/filing/0001493152-23-004521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315223004521/0001493152-23-004521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315223004521/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T15:57:07.373936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a96d81e1176e21b2541be1fe478346c37be280e5","claim":"Glucotrack, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)).","evidence_excerpt":"February 7, 2023, Nasdaq issued a letter to the Company granting an extension until May 22, 2023 to obtain compliance with the Listing Rule 5550(b) (the “Rule”), which requires a minimum $2,500,000 stockholders’ equity, $35,000,000 market value of listed securities, or $500,000 net income from continuing operations, notice of noncompliance with which was provided by Nasdaq to the Company on November 22, 2022. Nasdaq has granted the Company an extension to comply through either one or both of an acquisition or equity capital raise on or before May 22, 2023.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315223004521/0001493152-23-004521-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}